Scynexis (SCYX) Cash from Restructuring (2014 - 2016)
Scynexis' (SCYX) quarterly Cash from Restructuring came in at -$8000.0 in Q4 2016, up 96.23% quarter-over-quarter from -$212000.0 in Q3 2016.
Analysis
Scynexis (SCYX) Cash from Restructuring (2014 - 2016) Analysis & Trends
Scynexis (SCYX) has reported Cash from Restructuring for 3 consecutive years, with -$8000.0 the latest figure, recorded in Q4 2016.
- For the quarter ending Q4 2016, Cash from Restructuring changed N/A year-over-year to -$8000.0; the trailing twelve-month figure through Sep 2017 stood at -$8000.0 (up 99.39% YoY), and the FY2016 full-year result was -$2.6 million, changed N/A from the prior year.
- Cash from Restructuring improved to -$8000.0 in Q4 2016 per SCYX's latest filing, from -$212000.0 in the prior quarter.
- Across five years, Cash from Restructuring topped out at $1.5 million in Q2 2015 and bottomed at -$1.8 million in Q1 2016.
- Historically, Cash from Restructuring has averaged -$31285.7 across 3 years, with a median of -$212000.0 in 2016.
- The sharpest annual moves came in 2015 and 2016: Cash from Restructuring soared 436.76% in 2015, then tumbled 140.69% in 2016.
- Over 3 years, Cash from Restructuring stood at -$389000.0 in 2014, then jumped by 436.76% to $1.3 million in 2015, then sank by 100.61% to -$8000.0 in 2016.
- According to Business Quant data, Cash from Restructuring over the past three periods registered -$8000.0, -$212000.0, and -$610000.0 for Q4 2016, Q3 2016, and Q2 2016 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | -8,000.00 |
| Sep 30, 2016 | -212,000.00 |
| Jun 30, 2016 | -610,000.00 |
| Mar 31, 2016 | -1.81 Mn |
| Sep 30, 2015 | 1.31 Mn |
| Jun 30, 2015 | 1.50 Mn |
| Sep 30, 2014 | -389,000.00 |